Cargando…
Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)‐affiliated clinical trials
BACKGROUND: Cancer trial accrual is a national priority, yet up to 20% of trials fail to accrue. Trial eligibility criteria growth may be associated with accrual failure. We sought to quantify eligibility criteria growth within National Cancer Institute (NCI)‐affiliated trials and determine impact o...
Autores principales: | Peterson, John S., Plana, Deborah, Bitterman, Danielle S., Johnson, Skyler Bryce, Aerts, Hugo J. W. L., Kann, Benjamin Harris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972031/ https://www.ncbi.nlm.nih.gov/pubmed/36398619 http://dx.doi.org/10.1002/cam4.5276 |
Ejemplares similares
-
Characteristics and Causes for Non-Accrued Clinical Research (NACR) at an Academic Medical Institution
por: Tice, Debra G., et al.
Publicado: (2013) -
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation
por: Samson, Susan, et al.
Publicado: (2021) -
Barriers to accrue to clinical trials and possible solutions
por: Winters, Z E, et al.
Publicado: (2014) -
Interpretation of Results from Under‐accruing Studies
por: Kravets, Sasha, et al.
Publicado: (2018) -
Tumor-specific activity of precision medicines in the NCI-MATCH trial
por: Zhou, Ivvone, et al.
Publicado: (2023)